EyePoint Pharmaceuticals Inc (NASDAQ:EYPT)
| 7.98 BATS BZX Real-Time Price As of 1:36pm ET |  +0.18 / +2.31%Today’s Change | 7.00 Today|||52-Week Range 21.50 | -34.80% Year-to-Date |
Latest EYPT News | Press Releases
| EyePoint Pharmaceuticals (EYPT) Loses 25.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner Jun 27 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 7.80 |
| Today’s open | 8.02 |
| Day’s range | 7.90 - 8.03 |
| Volume | 1,868 |
| Average volume (3 months) | 142,769 |
| Market cap | $263.9M |
Data as of 1:36pm ET, 07/07/2022
Growth & Valuation
| Earnings growth (last year) | +42.56% |
| Earnings growth (this year) | -3,613.35% |
| Earnings growth (next 5 years) | +13.90% |
| Revenue growth (last year) | +7.27% |
| P/E ratio | NM |
| Price/Sales | 9.53 |
| Price/Book | 1.42 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| EVLOEvelo Biosciences In... | -0.11 | -4.49% |
| LQDALiquidia Corp | +0.20 | +4.77% |
| GTHXG1 Therapeutics Inc | -0.14 | -2.20% |
| VRNAVerona Pharma PLC | +0.27 | +6.44% |
Data as of 1:46pm ET, 07/07/2022
Financials
| Next reporting date | August 10, 2022 |
| EPS forecast (this quarter) | -$0.54 |
| Annual revenue (last year) | $36.9M |
| Annual profit (last year) | -$58.4M |
| Net profit margin | -158.14% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Watertown, Massachusetts |
Forecasts
